Evidence map›Paper›PMID 33725700›Full record

ArticleRespiration; international review of thoracic diseases2021

Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies.

Claudio Doglioni, Claudia Ravaglia, Marco Chilosi, Giulio Rossi, Alessandra Dubini, Federica Pedica, Sara Piciucchi, Antonio Vizzuso, Franco Stella, Stefano Maitan and 8 more

Open access · bronzeAbstract readComment
In one paragraph

Article in Respiration; international review of thoracic diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Cause of Death Analysis in a 9½-Year-Old with COVID-19 and Dravet Syndrome.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Kynurenine Pathway in Respiratory Diseases.International journal of tryptophan research : IJTR · 2024
    Review
  9. Review
  10. Article
  11. Observational
  12. Review
  13. COVID-19 and lung cancer.Pathologica · 2023
    Review
  14. Review
  15. Mesenchymal Stem Cells in the Treatment of COVID-19.International journal of molecular sciences · 2023
    Review
  16. Amino acid metabolism in health and disease.Signal transduction and targeted therapy · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 3 countries.

Claudio DoglioniDepartment of Pathology, University Vita-Salute, Milan and San Raffaele Scientific Institute, Milan, Italy.
Claudia RavagliaPulmonology Unit, Thoracic Diseases Department, G.B. Morgagni Hospital, Forlì, Italy, claudiaravaglia79@gmail.com.
Marco ChilosiDepartment of Pathology, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.
Giulio RossiDepartment of Pathology, S. Maria delle Croci Hospital, Ravenna, Italy.
Alessandra DubiniDepartment of Pathology, G.B. Morgagni Hospital, Forlì, Italy.
Federica PedicaDepartment of Pathology, San Raffaele Scientific Institute, Milan, Italy.
Sara PiciucchiDepartment of Radiology, G.B. Morgagni Hospital, Forlì, Italy.
Antonio VizzusoDepartment of Radiology, G.B. Morgagni Hospital, Forlì, Italy.
Franco StellaAlma Mater Studiorum Bologna University, Thoracic Surgery Unit, G.B. Morgagni Hospital, Forlì, Italy.
Stefano MaitanIntensive Care Unit, G.B. Morgagni Hospital, Forlì, Italy.
Vanni AgnolettiIntensive Care Unit, M. Bufalini Hospital, Cesena, Italy.
Silvia PuglisiPulmonology Unit, Thoracic Diseases Department, G.B. Morgagni Hospital, Forlì, Italy.
Giovanni PolettiClinical Pathology Unit, The Great Romagna Area Hub Laboratory, Pievesestina, Cesena, Italy.
Vittorio SambriMicrobiology Unit, The Great Romagna Area Hub Laboratory, Pievesestina, Cesena, Italy.
Giovanni PizzoloVerona University, Verona, Italy.
Vincenzo BronteImmunology Section, Department of Medicine, Verona University Hospital, Verona, Italy.
Athol U WellsInterstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom.
Venerino PolettiPulmonology Unit, Thoracic Diseases Department, G.B. Morgagni Hospital, Forlì, Italy.
Ospedale G.B. Morgagni - L.Pierantoni · ITUniversity of Bologna · ITUniversity of Verona · ITAarhus University Hospital · DKAzienda Unità Sanitaria Locale Della Romagna · ITCasa di Cura Villa Garda · ITOspedale “M. Bufalini” di Cesena · ITOspedale "Santa Maria delle Croci" di Ravenna · ITRoyal Brompton Hospital · GBSan Raffaele University of Rome · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe pathogenetic steps leading to Covid-19 interstitial pneumonia remain to be clarified. Most postmortem studies to date reveal diffuse alveolar damage as the most relevant histologic pattern. Antemortem lung biopsy may however provide more precise data regarding the earlier stages of the disease, providing a basis for novel treatment approaches.

objectivesTo ascertain the morphological and immunohistochemical features of lung samples obtained in patients with moderate Covid-19 pneumonia.

methodsTransbronchial lung cryobiopsy was carried out in 12 Covid-19 patients within 20 days of symptom onset.

resultsHistopathologic changes included spots of patchy acute lung injury with alveolar type II cell hyperplasia, with no evidence of hyaline membranes. Strong nuclear expression of phosphorylated STAT3 was observed in >50% of AECII. Interalveolar capillaries showed enlarged lumen and were in part arranged in superposed rows. Pulmonary venules were characterized by luminal enlargement, thickened walls, and perivascular CD4+ T-cell infiltration. A strong nuclear expression of phosphorylated STAT3, associated with PD-L1 and IDO expression, was observed in endothelial cells of venules and interstitial capillaries. Alveolar spaces macrophages exhibited a peculiar phenotype (CD68, CD11c, CD14, CD205, CD206, CD123/IL3AR, and PD-L1).

conclusionsMorphologically distinct features were identified in early stages of Covid-19 pneumonia, with epithelial and endothelial cell abnormalities different from either classical interstitial lung diseases or diffuse alveolar damage. Alveolar type II cell hyperplasia was a prominent event in the majority of cases. Inflammatory cells expressed peculiar phenotypes. No evidence of hyaline membranes and endothelial changes characterized by IDO expression might in part explain the compliance and the characteristic pulmonary vasoplegia observed in less-advanced Covid-19 pneumonia.

Indexed as

COVID-19Lung Diseases, InterstitialAutopsyEndothelial CellsHumansLungSARS-CoV-2Tomography, X-Ray ComputedAcute respiratory distress syndromeCoronavirusCovid-19CryobiopsyIndoleamine 2,3-dioxygenase-1Lung biopsypSTAT-3SARS-CoV-2

Identifiers

PMID33725700
PMCPMC8018216
OpenAlexW3138279939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.